Table 3.
Comorbidities in the study participants (n = 312).
| Health Condition | Frequency | DEQ-5 Score | OSDI Score | |||||
|---|---|---|---|---|---|---|---|---|
| n | % | M | SD | p-Value | M | SD | p-Value | |
| Arterial hypertension | 10 | 3.2 | 10.1 | 6.2 | =0.165 | 29.6 | 29.0 | =0.299 |
| Heart disease | 6 | 1.9 | 9.0 | 7.5 | =0.778 | 30.7 | 35.7 | =0.620 |
| Depression | 37 | 11.9 | 9.7 | 5.2 | =0.005 | 30.6 | 20.8 | <0.001 |
| Mental disease | 17 | 5.4 | 9.6 | 5.9 | =0.127 | 34.0 | 28.0 | =0.019 |
| Thyroid disease | 37 | 11.9 | 8.5 | 5.4 | =0.219 | 26.8 | 24.8 | =0.155 |
| Diabetes | 8 | 2.6 | 13.9 | 5.1 | =0.001 | 44.8 | 29.7 | =0.008 |
| Allergy | 77 | 24.7 | 8.7 | 4.7 | =0.023 | 25.4 | 19.6 | =0.002 |
| Acne | 13 | 4.2 | 9.5 | 6.2 | =0.242 | 30.3 | 29.0 | =0.210 |
M—mean; SD—standard deviation.